Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Debt to Equity (2016 - 2024)

Historic Debt to Equity for Neuroone Medical Technologies (NMTC) over the last 7 years, with Q1 2024 value amounting to $0.03.

  • Neuroone Medical Technologies' Debt to Equity changed N/A to $0.03 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.03, marking a year-over-year change of. This contributed to the annual value of $0.02 for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Neuroone Medical Technologies' Debt to Equity stood at $0.03.
  • In the past 5 years, Neuroone Medical Technologies' Debt to Equity registered a high of $0.03 during Q1 2024, and its lowest value of $0.02 during Q3 2023.